In this episode, Dr Goel discusses the availability of a new blood test to diagnose Alzheimer’s disease called the p tau217 antibody test. Plus, explore advanced cognitive screening methods now available, offering insights into mild cognitive impairment years before Alzheimer’s onset. Stay informed, engage with us in the comments, and together, let’s pave the way for prevention and breakthroughs in Alzheimer’s research.
TIMESTAMPS:
00:00 – Introduction
00:32 – New Blood Test: The P Tau217 Antibody
01:57 – Expanded Testing Options: Cognitive Function Screening
03:57 – Understanding Mild Cognitive Impairment (MCI)
04:51 – Importance of Early Screening and Prevention
05:58 – Conclusion
📚 PURCHASE DR. SANJEEV GOEL’S BOOK “The Top 10 Must Do Peak Human Biohacks of 2023″📚
→ iBooks: https://books.apple.com/ca/book/top-1…
→ Kobo: https://www.kobo.com/ca/en/ebook/the-…
→ Amazon – https://www.amazon.com/dp/B0C1J2N1YF
📚 Purchase the Peak Longevity Prediction Pack 📚
→ https://peakhuman.ca/product/peak-lon…
Visit our website: https://peakhuman.ca/?v=3e8d115eb4b3
https://peakhuman.ca/lead-generation-…
Shop here: https://peakhuman.ca/shop/
Subscribe on YouTube: https://bit.ly/PeakHumanLabs
